Trial Profile
A Non-Interventional, Open Label, Phase IV Observational Study for the Safety and Efficacy of Switching to Quetiapine (Seroquel) in Outpatients With Schizophrenia Who Have Been Unsuccessfully Treated With Other Antipsychotics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2010
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Acronyms Q-chase
- Sponsors AstraZeneca
- 25 Jun 2008 New trial record.